Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting

Dolutegravir’s therapeutic effectiveness in the management of neuroAIDS is mainly limited by its failure to cross the blood–brain barrier. However, lipid-based nanovesicles such as nanoemulsions have demonstrated their potential for the brain targeting of various drugs by intranasal delivery. Thus,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anroop B. Nair, Sunita Chaudhary, Shery Jacob, Dhwani Patel, Pottathil Shinu, Hiral Shah, Ankit Chaudhary, Bandar Aldhubiab, Rashed M. Almuqbil, Ahmed S. Alnaim, Fatemah Alqattan, Jigar Shah
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-02-01
coleção:	Gels
Assuntos:	NeuroAIDS Dolutegravir nanoemulsion nasal in situ gel mucoadhesive brain targeting
Acesso em linha:	https://www.mdpi.com/2310-2861/9/2/130
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!